| Entry |
|
|---|
| Name |
Glycopyrronium tosylate (USAN);
Glycopyrronium tosilate hydrate (JAN);
Glycopyrronium tosylate monohydrate;
Qbrexza (TN);
Rapifort (TN) |
|---|
| Product |
|
|---|
| Formula |
C19H28NO3. C7H7O3S. H2O
|
|---|
| Exact mass |
507.2291
|
|---|
| Mol weight |
507.6395
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
|
|---|
| Remark |
| Therapeutic category: | 1259 |
| Product (DG02467): | D00540<JP/US> D10939<JP/US> |
|
|---|
| Efficacy |
Muscarinic acetylcholine receptor antagonist |
|---|
| Comment |
Treatment of hyperhidrosis
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AA Antihidrotics
D11AA01 Glycopyrronium
D10939 Glycopyrronium tosylate (USAN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Dermatological Agents, Miscellaneous
Glycopyrronium
D10939 Glycopyrronium tosylate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
125 Diaphoretics, anhidrotics
1259 Others
D10939 Glycopyrronium tosylate (USAN); Glycopyrronium tosilate hydrate (JAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG02467 Glycopyrronium
D10939 Glycopyrronium tosylate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D10939 Glycopyrronium tosylate (USAN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10939
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG02467 Glycopyrronium
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 35
1 C1d C 16.0531 -16.8474
2 C7a C 14.9201 -17.4847
3 O7a O 13.7162 -16.8474
4 O6a O 14.9201 -18.9010
5 C1y C 12.4415 -17.5556
6 C1x C 11.3628 -16.7766
7 C1x C 12.0408 -18.9214
8 N2y N 10.2055 -17.5679 #+
9 C1x C 10.6793 -18.8818
10 C1y C 17.2717 -17.5692
11 C1x C 17.7108 -18.8972
12 C1x C 19.1120 -18.8938
13 C1x C 19.5416 -17.5600
14 C1x C 18.4060 -16.7393
15 C8y C 16.0531 -15.4311
16 C8x C 17.2797 -14.7229
17 C8x C 17.2797 -13.3067
18 C8x C 16.0531 -12.5985
19 C8x C 14.8266 -13.3067
20 C8x C 14.8266 -14.7229
21 O1a O 17.1381 -15.9976
22 C1a C 8.9790 -16.8598
23 C1a C 8.9790 -18.2760
24 C8x C 22.1903 -16.2402
25 C8x C 22.1903 -17.6402
26 C8y C 23.4027 -18.3402
27 C8x C 24.6152 -17.6402
28 C8x C 24.6152 -16.2402
29 C8y C 23.4027 -15.5402
30 C1a C 23.4027 -19.7400
31 S4a S 23.4027 -14.1404
32 O1d O 23.4027 -12.7404 #-
33 O1d O 24.8027 -14.1404
34 O1d O 22.0027 -14.1404
35 O0 O 28.3504 -16.8002
BOND 36
1 1 2 1
2 2 3 1
3 2 4 2
4 3 5 1
5 5 6 1
6 5 7 1
7 6 8 1
8 7 9 1
9 8 9 1
10 1 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 10 14 1
16 1 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 15 20 2
23 1 21 1
24 8 22 1
25 8 23 1
26 24 25 2
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 24 29 1
32 26 30 1
33 29 31 1
34 31 32 1
35 31 33 2
36 31 34 2
|
|---|
